Hyalex is a medical device company developing artificial cartilage based on technology licensed from Stanford University, Hyalex is developing a breakthrough synthetic biomaterial with properties that mimic the structure and function of the hyaline cartilage that lines articulating joints, such as the hip, knee, shoulder and ankle. The HYALEX polymer has the potential to replace damaged cartilage in joints, creating the opportunity for a less invasive, more anatomic solution in disease states such as osteoarthritis or cartilage injuries.